Dr. Alan C. Dalkin reviews medical content for Healthwise, a
nonprofit organization with a mission to help people make better health
decisions. Dr. Dalkin is an internist who specializes in endocrinology and
metabolism. He has a particular interest in the diagnosis and treatment of
osteoporosis. He has been affiliated with the University of Virginia Health
Sciences Center in Charlottesville, Virginia, since 1991 and was named
Associate Professor of Internal Medicine in 1997 and Professor of Internal
Medicine in 2007.
Dr. Dalkin is active in scientific research and has coauthored book
chapters, abstracts, and articles published in leading medical journals. He has
presented dozens of papers and has been invited to speak at national and
regional endocrinology conferences. In addition, he serves as an ad hoc
reviewer of articles for the journals Clinical Chemistry, Clinical Endocrinology, and
Endocrinology.
Board Certifications
American Board of Internal
Medicine-1987
ABIM Subspecialty in Endocrinology and
Metabolism-1990
Healthwise Knowledgebase Topics Reviewed
Hypothyroidism
Medical test
topics related to Endocrinology, including Blood Glucose Test, Glucose
Tolerance Test, and Bone Mineral Density
Diabetes
Addison's Disease
Education
MD: University of Michigan Medical School,
1984
Internship and Residency in Internal Medicine: University of
Chicago Hospitals, 1984-1987
Fellowship in Endocrinology and
Metabolism: University of Michigan Medical Center, Ann Arbor, 1987-1990
Academic Appointments
University of Michigan Medical Center, Ann
Arbor, Assistant Professor of Internal Medicine,
1990-1991
University of Virginia Health Sciences Center,
Charlottesville, Division of Endocrinology and Metabolism, Dept. of Internal
Medicine:
Assistant Professor of Internal Medicine,
1991-1997
Associate Professor of Internal Medicine,
1997-2007
Professor of Internal Medicine, 2007-present
Professional Affiliations
American College of
Physicians
Endocrine Society
The Pituitary Society,
Society for the Study of Reproduction
Selected Publications
Prendergast KA, Burger LL, Aylor KW,
Haisenleder DJ, Dalkin AC, Marshall JC (2004). Pituitary follistatin gene
expression in female rats: Evidence that inhibin regulates transcription.
Biology of Reproduction, 70(2):
364-370.
Haisenleder DJ, Burger LL, Aylor KW, Dalkin AC, Walsh HE,
Shupnik MA, Marshall JC (2005). Testosterone stimulates FSH beta transcription
via activation of extracellular signal-regulated kinase (ERK) in rat pituitary
cells. Biology of Reproduction, 72(3): 523-529.
Imel EA, Peacock M, Pitukcheewanont P, Heller H, Ward L, Shulman
D, Kassem M, Rackoff P, Zimering M, Dalkin A, Drobney E, Colussi G, Shaker J,
Hoogendorn E, Evans W, Econs MJ (2006). The sensitivity of Fibroblast Growth
Factor 23 measurements in tumor induced osteomalacia. Journal of Clinical Endocrinology and Metabolism, 91(6): 2055-2061.
Javorsky B, Dalkin AC (2007). Hypercalcemia: A practical approach
to a surprising condition. Emergency Medicine; 39(9):
13-20.
Pinkerton JV, Dalkin AC (2007). Combination therapy for
treatment of osteoporosis: A review. American Journal of Obstetrics and Gynecology, 197(5): 559-565.
Financial Disclosure
Dr. Dalkin is on the Speaker's Bureau for Merck and Co.
